Here, we examined the anti-asthma effect of Andrographolide and provided the data which showed that Andrographolide significantly reduced NF-κB and NLRP3 inflammasome activation and finally alleviated the symptoms in OVA-treated mice. Here, NLRP3 is linked to asthma.